Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03080254
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
5AX | 2-(ACETYLAMINO)-1,5-ANHYDRO-2-DEOXY- D-GLUCITOL | A | 2JCQ | 0.7 |  |
| 5AX | 2-(ACETYLAMINO)-1,5-ANHYDRO-2-DEOXY- D-GLUCITOL | A,B | 2IH9 | 0.7 | |
| 5AX | 2-(ACETYLAMINO)-1,5-ANHYDRO-2-DEOXY- D-GLUCITOL | A,B,C,D,E,F | 2J2P | 0.7 | |
| 5AX | 2-(ACETYLAMINO)-1,5-ANHYDRO-2-DEOXY- D-GLUCITOL | A | 3DIV | 0.7 | |
AMU | BETA-N-ACETYLMURAMIC ACID | A,B,C,D | 2APH | 0.73 | |
| AMU | BETA-N-ACETYLMURAMIC ACID | A,P | 1TWQ | 0.73 | |
| AMU | BETA-N-ACETYLMURAMIC ACID | A | 1D0K | 0.73 | |
| AMU | BETA-N-ACETYLMURAMIC ACID | S | 9LYZ | 0.73 | |
| AMU | BETA-N-ACETYLMURAMIC ACID | E,S | 148L | 0.73 | |
| AMU | BETA-N-ACETYLMURAMIC ACID | D,K | 3CYQ | 0.73 | |
| AMU | BETA-N-ACETYLMURAMIC ACID | U | 2AIZ | 0.73 | |
AHY | (2S,3R)-3-AMINO-2-HYDROXYDECANOIC ACID | A,D | 2J9A | 0.71 | |
233 | [5-(3,4,5-TRIHYDROXY-6-HYDROXYMETHYL- TETRAHYDRO-PYRAN-2-YLCARBAMOYL)- PENTYL]-CARBAMIC ACID METHYL ESTER | D,E,F,G,H | 1MD2 | 0.72 | |
AMV | METHYL 2-(ACETYLAMINO)-3-O-[(1R)- 1-CARBOXYETHYL]-2-DEOXY-BETA-D- GLUCOPYRANOSIDE | A | 2J8G | 0.72 | |
| AMV | METHYL 2-(ACETYLAMINO)-3-O-[(1R)- 1-CARBOXYETHYL]-2-DEOXY-BETA-D- GLUCOPYRANOSIDE | A | 2J8F | 0.72 | |
ANA | 4-O-ACETYL-ALPHA-2-OMETHYL-5-N- ACETYL-ALPHA-D-NEURAMINIC ACID | A,B,C,D,E,F | 1HGI | 0.82 | |
HG9 | 1-DEOXY-1-[(2-HYDROXYETHYL)(NONANOYL)AMINO]HEXITOL | A,B,C,D | 1SO2 | 0.71 | |
GNA | 2,4-DEOXY-4-GUANIDINO-5-N-ACETYL- NEURAMINIC ACID | A | 2QWE | 0.78 | |
DYH | (2R,3aR,6S,7R,7aR)-2-[(2S)-2-amino- 2-carboxyethyl]-6-hydroxy-7-(methylamino)hexahydro- 2H-furo[3,2-b]pyran-2-carboxylic acid | A | 2ZNT | 0.7 | |
| DYH | (2R,3aR,6S,7R,7aR)-2-[(2S)-2-amino- 2-carboxyethyl]-6-hydroxy-7-(methylamino)hexahydro- 2H-furo[3,2-b]pyran-2-carboxylic acid | A,B,C,D | 3GBA | 0.7 | |
HQ6 | N-[(3R,4S,5R,6R,7R)-3,5,6-trihydroxy- 7-(hydroxymethyl)azepan-4-yl]acetamide | A,B | 2W66 | 0.74 | |
GDL | 2-ACETAMIDO-2-DEOXY-D-GLUCONO-1,5- LACTONE | A,B | 1UR9 | 0.76 | |
| GDL | 2-ACETAMIDO-2-DEOXY-D-GLUCONO-1,5- LACTONE | A,B,C,D,E,F | 1O7A | 0.76 | |
| GDL | 2-ACETAMIDO-2-DEOXY-D-GLUCONO-1,5- LACTONE | A,B | 1UR8 | 0.76 | |
LP4 | (R)-((2R,3S,4R,5S)-2-(HYDROXYMETHYL)- 5-((R)-3-HYDROXYTETRADECANAMIDO)- 3-(PHOSPHONOOXY)TETRAHYDRO-2H-PYRAN- 4-YL) 3-HYDROXYTETRADECANOATE | A | 2E59 | 0.75 | |
AMN | 9-DEOXY-9-AMINO-2-O-METHYL-5-N- ACETYL-ALPHA-D-NEURAMINIC ACID | A,B,C,D,E,F | 1HGJ | 0.81 | |
GSL | (2S,3R)-3-HYDROXY-2-(TETRADECANOYLAMINO)OCTADECYL ALPHA- D-GALACTOPYRANOSIDURONIC ACID | A | 2FIK | 0.71 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 3EMY | 0.7 | |
| IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 2H6T | 0.7 | |
| IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1LS5 | 0.7 | |
| IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1SME | 0.7 | |
| IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,C | 1W6I | 0.7 | |
| IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1XDH | 0.7 | |
| IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 2QZX | 0.7 | |
| IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 1IZE | 0.7 | |
| IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1M43 | 0.7 | |
G28 | 5-N-ACETYL-4-AMINO-6-DIETHYLCARBOXAMIDE- 4,5-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID | A | 2QWJ | 0.78 | |
| G28 | 5-N-ACETYL-4-AMINO-6-DIETHYLCARBOXAMIDE- 4,5-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID | A | 2QWG | 0.78 | |
ABW | 5-[1-(ACETYLAMINO)-3-METHYLBUTYL]- 2,5-ANHYDRO-3,4-DIDEOXY-4-(METHOXYCARBONYL)PENTONIC ACID | A | 1XOG | 0.75 | |
HMN | 2,4,6,7,8,9-HEXAHYDROXY-5-METHYLCARBOXAMIDO NONANOIC ACID | A,B,C,D | 1F73 | 0.92 | |
CNP | 2-PROPENYL-N-ACETYL-NEURAMIC ACID | A | 4SLI | 0.72 | |
FSI | 5-(ACETYLAMINO)-2,6-ANHYDRO-3,5- DIDEOXY-3-FLUORONONONIC ACID | A | 2AH2 | 0.83 | |
| FSI | 5-(ACETYLAMINO)-2,6-ANHYDRO-3,5- DIDEOXY-3-FLUORONONONIC ACID | A | 2FHR | 0.83 | |
| FSI | 5-(ACETYLAMINO)-2,6-ANHYDRO-3,5- DIDEOXY-3-FLUORONONONIC ACID | A | 2A75 | 0.83 | |
| FSI | 5-(ACETYLAMINO)-2,6-ANHYDRO-3,5- DIDEOXY-3-FLUORONONONIC ACID | A,B | 2VK7 | 0.83 | |